Patient Support Line 1-866-433-8000, Monday-Friday: 8:00 AM to 8:00 PM ET

Understanding your early breast cancer diagnosis
If you've been diagnosed with early breast cancer (eBC for short), you probably have a lot of questions. Here's some information about your condition, a treatment option, and tips on how to speak with your health care team.
What's early breast cancer?
Let's start with the diagnosis. Early breast cancer means that the cancer is found only in the breast or nearby lymph nodes. It also means it has not spread to other parts of the body.
Real facts & stats about breast cancer
In the United States alone, there will be over 321,900 women diagnosed with breast cancer in 2026. This doesn't include the estimated 2,670 men who will also be diagnosed. Developing the right treatment plan with your doctor is an important first step.
Stages of early breast cancer
The stage of a cancer describes how much cancer is in the body. Knowing the stage helps determine how serious the cancer is and how best to treat it. Stages 0, 1, 2, and 3 are considered early breast cancer.
The cancer is in the same part of the breast as it started, sometimes called noninvasive breast cancer.
The tumor is small and either has not spread or may have spread in small amounts to lymph nodes close to the breast.
The tumor is a little larger and/or has spread to more lymph nodes than in stage 1 cancer.
The tumor may be larger, may have started growing into nearby tissue, or may have spread to many nearby lymph nodes. Stage 3 is also called locally advanced breast cancer.
There are 4 main subtypes of early breast cancer:
A subtype is a way of grouping cancer by what fuels its growth. Breast cancer subtypes are made up of 2 different parts: hormone receptor (HR) status and human epidermal growth factor receptor 2 (HER2) status.
Breast cancer subtypes may determine:
• How your cancer responds to different treatments
• How you and your doctor decide what treatment options are right for you
HR+, HER2- cancer cells have hormone receptors and make small amounts or no amounts of HER2 protein.
HR+, HER2+ cancer cells have hormone receptors and make high levels of HER2 protein.
HR-, HER2+ cancer cells don't have hormone receptors but do make high levels of HER2 protein.
Triple-negative cancer cells don't have hormone receptors for estrogen or progesterone. They also make low to no amounts of the HER2 protein.
DID YOU KNOW?HR+, HER2- breast cancer is the most common subtype, accounting for about 70% of all breast cancer cases. |
Tips for talking to your doctor about breast cancer:
Discuss your treatment options | |
Establish your treatment goals | |
Make a list of questions for your next appointment |
Key terms and definitions for understanding early breast cancer
Learn more about these terms commonly used by your health care team, the medical community, and throughout your treatment journey.
